 |
|
|
REFERENCES
1.
Blundell J: Some account of a case of obstinate
vomiting in which an attempt was made to prolong life by the injection of blood into
the veins. Med Chir Trans 10:296, 1819.
2.
Fantus B: The therapy of the Cook County Hospital.
JAMA 109:128, 1937.
3.
Goodnough LT, Shander A, Spence RK: Bloodless medicine:
clinical care without allogeneic blood transfusion. Transfusion 43:668, 2003.
4.
NHLBI Expert Panel: Transfusion alert: Use of
autologous blood. Transfusion 35:703, 1995.
5.
Goodnough LT, Brecher ME, Kanter MH, et al: Medical
progress: Transfusion medicine, Part II. Blood conservation. N Engl J Med 340:525,
1999.
6.
Goodnough LT, Shander A, Brecher ME: Transfusion
medicine: Looking toward the future. Lancet 361:161, 2003.
7.
Goodnough LT, Brecher ME, Kanter MH, et al: Medical
progress: Transfusion medicine, Part I. Blood transfusion. N Engl J Med 340:439,
1999.
8.
Brecher ME, Goodnough LT: The rise and fall in
preoperative autologous blood donation. Transfusion 42:1618, 2002.
9.
Finucane ML, Slovic P, Mertz CK: Public perception
of the risk of blood transfusion. Transfusion 40:1017, 2002.
10.
Lockwood CD: Surgical treatment of Banti's disease.
Surg Gynecol Obstet 25:188, 1917.
11.
Watson CM, Watson JR: Autotransfusion: Review
of the literature with report of two additional cases. Am J Surg 33:232, 1936.
12.
Davis LE, Cushing H: Experiences with blood replacement
during or after major intracranial operations. Surg Gynecol Obstet 40:310, 1925.
13.
Farrar LK: Autotransfusion—blood transfusion
in gynecology. Surg Gynecol Obstet 36:454, 1923.
14.
Griswold RA, Ortner AB: The use of autotransfusion
in surgery of the serous cavities. Surg Gynecol Obstet 77:167, 1943.
15.
Brown AAL, Debenham MW: Autotransfusion use of
blood from hemothorax. JAMA 96:1223, 1931.
16.
Symbas PN: Extraoperative autotransfusion from
hemothorax. Surgery 84:722, 1978.
17.
Dyer RH: Intra-operative autotransfusion, a preliminary
report and a new method. Am J Surg 112:874, 1966.
18.
Wilson JD, Utz DC, Taswell HF: Autotransfusion
during transurethral resection of the prostate: Technique and preliminary clinical
evaluation. Mayo Clin Proc 44:374, 1969.
19.
Klebanoff G: Early experience with a disposable
unit for intraoperative salvage and reinfusion of blood loss (intraoperative autotransfusion).
Am J Surg 120:351, 1970.
20.
Noon GP, Solis RT, Natelson EA: A simple method
of intraoperative autotransfusion. Surg Gynecol Obstet 143:65, 1976.
21.
American Association of Blood Banks: Standards
for Blood Banks and Transfusion Services, 21st ed. Bethesda, MD, American Association
of Blood Banks, 2002.
22.
Mintz PD: Participation of HIV-infected patients
in autologous blood programs. JAMA 269:2892, 1993.
23.
Mintz PD, Nordine RB, Henry JB, et al: Expected
hemotherapy in elective surgery. N Y State J Med 76:532, 1976.
24.
Goodnough LT: Preoperative autologous donation.
In Spence RK (ed): Problems in General Surgery.
Philadelphia, Lippincott Williams & Wilkins, 2000, pp 25–31.
25.
Bierbaum BE, Callaghan JJ, Galante JO, et al:
An analysis of blood management in patients having total hip or knee arthroplasty.
J Bone J Surg 81A:2, 1999.
26.
Renner SW, Howanitz PJ, Bachner P: Preoperative
autologous blood donation in 612 hospitals. Arch Pathol Lab Med 116:613, 1992.
27.
Silvergleid AJ: Safety and effectiveness of predeposit
autologous transfusions in preteen and adolescent children. JAMA 257:3403, 1987.
28.
Mann M, Sacks HJ, Goldfinger D: Safety of autologous
blood donation prior to elective surgery for a variety of potentially high risk patients.
Transfusion 23:229, 1983.
29.
Popovsky MA, Whitaker B, Arnold NL: Severe outcomes
of allogeneic and autologous blood donation: Frequency and characterization. Transfusion
35:734, 1995.
30.
Thomas MJG, Gillon J, Desmond MJ: Preoperative
autologous blood donation. Transfusion 36:633, 1996.
31.
Sayers MH: Controversies in transfusion medicine.
Autologous blood donation in pregnancy: Con. Transfusion 30:172, 1990.
32.
Larocque BJ, Gilbert K, Brien WF: Prospective
validation of a point score system for predicting blood transfusion following hip
or knee replacement. Transfusion 38:932, 1998.
33.
Brecher MA, Monk TG, Goodnough LT: A standardized
method for calculating blood loss. Transfusion 37:1070, 1997.
34.
Goodnough LT, Skikne B, Brugnara C: Erythropoietin,
iron, and erythropoiesis. Blood 96:823, 2000.
35.
Kasper SM, Gerlich W, Buzello W: Preoperative
red cell production in patients undergoing weekly autologous blood donation. Transfusion
37:1058, 1997.
36.
Kasper SM, Lazansky H, Stark C, et al: Efficacy
of oral iron supplementation is not enhanced by additional intravenous iron during
autologous blood donation. Transfusion 38:764, 1998.
37.
Weisbach V, Skoda P, Rippel R, et al: Oral or
intravenous iron as an adjunct to autologous blood donation in elective surgery:
A randomized, controlled study. Transfusion 39:465, 1999.
38.
Cohen JA, Brecher ME: Preoperative autologous
blood donation: Benefit or detriment? A mathematical analysis. Transfusion 35:640,
1995.
39.
Kanter MH, Van Maanen D, Anders KH, et al: Preoperative
autologous blood donation before elective hysterectomy. JAMA 276:798, 1996.
40.
Goodnough LT, Rudnick S, Price TH, et al: Increased
preoperative collection of autologous blood with recombinant human erythropoietin
therapy, N Engl J Med 321:1163, 1989.
41.
Goodnough LT, Price TH, Rudnick S, et al: Preoperative
red blood cell production in patients undergoing aggressive autologous blood phlebotomy
with and without erythropoietin therapy. Transfusion 32:441, 1992.
42.
Goodnough LT, Price TH, Friedman KD, et al: A
phase III trial of recombinant human erythropoietin therapy in non-anemic orthopedic
patients subjected to aggressive autologous blood phlebotomy: Dose, response, toxicity,
efficacy. Transfusion 34:66, 1994.
43.
Goodnough LT, Monk TG, Andriole GL: Erythropoietin
therapy. N Engl J Med 336:933, 1997.
44.
National Heart, Lung, and Blood Institute Autologous
Transfusion Symposium Working Group. Autologous transfusion: Current trends and
research issues. Transfusion 35:525, 1995.
45.
Linden JV, Wagner K, Voytovich AE, et al: Transfusion
errors in New York State: An analysis of 10 years' experience. Transfusion 40:1207,
2000.
46.
Hebert PC, Wells G, Blaschman MA, et al: A multicenter,
randomized, controlled clinical trial of transfusion requirements in critical care.
N Engl J Med 340:409, 1999.
47.
Birkmeyer JD, AuBuchon JP, Littenberg B, et al:
Cost-effectiveness of preoperative autologous donation in coronary artery bypass
grafting. Ann Thorac Surg 57:161, 1994.
48.
Etchason J, Petz L, Keeler E, et al: The cost
effectiveness of preoperative autologous blood donations. N Engl J Med 332:719,
1995.
49.
Birkmeyer JD, Goodnough LT, AuBuchon JP, et al:
The cost-effectiveness of preoperative autologous blood donation for total hip and
knee replacement. Transfusion 33:544, 1996.
50.
Goodnough LT, Brecher ME, Monk TG: Acute normovolemic
hemodilution in surgery. Hematology 2:413–20, 1992.
51.
Goodnough LT, Brecher ME, Kanter MH, et al: Transfusion
medicine. Second of two parts. Blood conservation. N Engl J Med 340(7):525, 1999.
52.
Messmer K, Kreimeier M, Intagliett A: Present
state of intentional hemodilution. Eur Surg Res 18:254, 1986.
53.
Brecher ME, Rosenfeld M: Mathematical and computer
modeling of acute normovolemic hemodilution. Transfusion 34:176, 1994.
54.
Goodnough LT, Bravo J, Hsueh Y, et al: Red blood
cell volume in autologous and homologous units: Implications for risk/benefit assessment
for autologous blood "crossover" and directed blood transfusion. Transfusion 29:821,
1989.
55.
Goodnough LT, Grishaber JE, Monk TG, et al: Acute
normovolemic hemodilution in patients undergoing radical suprapubic prostatectomy:
A case study analysis. Anesth Analg 78:932, 1994.
56.
Weiskopf RB: Mathematical analysis of isovolemic
hemodilution indicates that it can decrease the need for allogeneic blood transfusion.
Transfusion 35:37, 1995.
57.
Petry AF, Jost T, Sievers H: Reduction of homologous
blood requirements by blood pooling at the onset of cardiopulmonary bypass. J Thorac
Cardiovasc Surg 1097:1210, 1994.
58.
Monk TG, Goodnough LT, Brecher ME, et al: A prospective,
randomized trial of three blood conservation strategies for radical prostatectomy.
Anesth 91:24, 1999.
59.
Goodnough LT, Merkel K, Monk TG, et al: A randomized
trial of acute normovolemic hemodilution compared to preoperative autologous blood
donation in total knee arthroplasty. Vox Sang 1999;77:11, 1999.
60.
Goodnough LT, Despotis GJ, Merkel K, et al: A
randomized trial of acute normovolemic hemodilution compared to preoperative autologous
blood donation in total hip arthroplasty. Transfusion 40:1054, 2000.
61.
Davies MJ, Cronin KD, Domaingue C: Haemodilution
for major vascular surgery using 3.5% polygeline (Haemaccel). Anaesth Intensive
Care 10:265, 1982.
62.
Sejourne P. Poirier A, Meakins JL, et al: Effects
of haemodilution on transfusion requirements in liver resection. Lancet 2:1380,
1989.
63.
Rosenberg B, Wulff K: Regional lung function following
hip arthroplasty and preoperative normovolemic hemodilution. Acta Anaesthesiol Scand
23:242, 1979.
64.
Kafer ER, Isley MR, Hansen T, et al: Automated
acute normovolemic hemodilution reduces blood transfusion requirements for spinal
fusion [abstract]. Anesth Analg 65(Suppl):S76, 1986.
65.
Rose D, Coustoftides T: Intraoperative normovolemic
hemodilution. J Surg Res 31:375, 1981.
66.
Ness PM, Bourke DL, Walsh PC: A randomized trial
of perioperative hemodilution versus transfusion of preoperatively deposited autologous
blood in elective surgery. Transfusion 31:226, 1991.
67.
Monk TG, Goodnough LT, Birkmeyer JD, et al: Acute
normovolemic hemodilution is a cost-effective alternative to preoperative autologous
blood donation by patients undergoing radical retropubic prostatectomy. Transfusion
35:559, 1995.
68.
Shander A: Acute normovolemic hemodilution. In
Spence RK (ed): Problems in General Surgery. Philadelphia, Lippincott Williams
& Wilkins, 2000, pp 17–24.
69.
Monk TG, Goodnough LT, Brecher ME, et al: Acute
normovolemic hemodilution can replace preoperative autologous blood donation as a
standard of care for autologous blood procurement in radical prostatectomy. Anesth
Analg 85:953, 1997.
70.
Goodnough LT, Monk TG, Brecher ME: Acute normovolemic
hemodilution should replace preoperative autologous blood donation before elective
surgery. Transfusion 38:473, 1998.
71.
Monk TG: Is acute normovolemic hemodilution cost-effective?
Semin Anesth (in press).
72.
Briggs AH, O'Brien BJ: The death of cost-minimization
analysis? Health Econ 10:179, 2001.
73.
Williamson KR, Taswell HF: Intraoperative blood
salvage: A review. Transfusion 31:662, 1991.
74.
Domen RE: Adverse reactions associated with autologous
blood transfusion: Evaluation and incidence at a large academic hospital. Transfusion
38:296, 1998.
75.
Gregoretti S: Suction-induced hemolysis at various
vacuum pressures: Implications for intraoperative blood salvage. Transfusion 36:57,
1996.
76.
Bell K, Stott K, Sinclair CJ, et al: A controlled
trial of intraoperative autologous transfusion in cardiothoracic surgery measuring
effect on transfusion requirements and clinical outcome. Transfus Med 2:295, 1992.
77.
Solomon MD, Rutledge ML, Kane LE, et al: Cost
comparison of intraoperative autologous versus homologous transfusion. Transfusion
28:379, 1988.
78.
Bovill DF, Moulton CW, Jackson WS, et al: The
efficacy of intraoperative autologous transfusion in major orthopaedic surgery:
A regression analysis. Orthopedics 9:1403, 1986.
79.
Goodnough LT, Monk TG, Sicard G, et al: Intraoperative
salvage in patients undergoing elective abdominal aortic aneurysm repair. An analysis
of costs and benefits. J Vasc Surg 24:213, 1996.
80.
Claggett GP, Valentine RJ, Jackson MR, et al:
A randomized trial of intraoperative transfusion during aortic surgery. J Vasc Surg
29:22, 1999.
81.
Autologous Transfusion Committee. Guidelines for
blood recovery and reinfusion in surgery and trauma. Bethesda, MD, American Association
of Blood Banks, 1997.
82.
de Haan J, Boonstra P, Monnink S, et al: Retransfusion
of suctioned blood during cardiopulmonary bypass impairs hemostasis. Ann Thorac
Surg 59:901, 1995.
83.
Ward HB, Smith RA, Candis KP, et al: A prospective,
randomized trial of autotransfusion after routine cardiac surgery. Ann Thorac Surg
56:137, 1993.
84.
Thurer RL, Lytle BW, Cosgrove DM, et al: Autotransfusion
following cardiac operations: A randomized, prospective study. Ann Thorac Surg
27:500, 1979.
85.
Roberts SP, Early GL, Brown B, et al: Autotransfusion
of unwashed mediastinal shed blood fails to decrease banked blood requirements in
patients undergoing aorta coronary bypass surgery. Am J Surg 162:477, 1991.
86.
Schaff HV, Hauer JM, Bell WR, et al: Autotransfusion
of shed mediastinal blood after cardiac surgery. A prospective study. J Thorac
Cardiovasc Surg 75:632, 1978.
87.
Eng J, Kay PH, Murday AJ, et al: Post-operative
autologous transfusion in cardiac surgery. A prospective, randomized study. Eur
J Cardiothorac Surg 4:595, 1990.
88.
Semkiw LB, Schurman OJ, Goodman SB, et al: Postoperative
blood salvage using the cell saver after total joint arthroplasty. J Bone Joint
Surg (Am) 71A:823, 1989.
89.
Martin JW, Whiteside LA, Milliano MT, et al: Postoperative
blood retrieval and transfusion in cementless total knee arthroplasty. J Arthroplasty
20007:205, 1992.
90.
Umlas J, Foster RR, Dalal SA, et al: Red cell
loss following orthopedic surgery: The case against postoperative blood salvage.
Transfusion 34:402, 1994.
91.
Ritter MA, Keating EM, Faris PM: Closed wound
drainage in total hip or knee replacement: A prospective, randomized study. J Bone
J Surg 76:35, 1994.
92.
Clements DH, Sculco TP, Burke SW, et al: Salvage
and reinfusion of postoperative sanguineous wound drainage. J Bone Joint Surg (Am)
74A:646, 1992.
93.
Woda R, Tetzlaff JE: Upper airway oedema following
autologous blood transfusion from a wound drainage system. Can J Anesth 39:290,
1992.
94.
Blevins FT, Shaw B, Valeri RC, et al: Reinfusion
of shed blood after orthopaedic procedures in children and adolescents. J Bone Joint
Surg (Am) 75A:363, 1993.
95.
Goodnough LT, Verbrugge D, Marcus RE: The relationship
between hematocrit, blood lost, and blood transfused in total knee replacement:
Implications for postoperative blood salvage and reinfusion. Am J Knee Surg 8:83,
1995.
96.
Baker JW, Spotnitz WD, Matthew TL, et al: Mediastinal
fibrin glue: Hemostatic effect and tissue response in calves. Ann Thorac Surg 47:450,
1989.
97.
Silberstein LE, Williams LJ, Hughlett MA, et al:
An autologous fibrinogen-based adhesive for use in otologic surgery. Transfusion
28:319, 1988.
98.
Gibble JW, Ness PM: Fibrin glue: The perfect
operative sealant? Transfusion 30:741, 1990.
99.
Milde LN: An anaphylactic reaction to fibrin glue.
Anesth Analg 679:684, 1989.
100.
Wilson SM, Pell P, Donegan EA: HIV-1 transmission
following the use of cryoprecipitated fibrinogen as gel/adhesive [abstract]. Transfusion
31:51S, 1991.
101.
Burnouf-Radosevich M, Burnouf T, Huart JJ: Biochemical
and physical properties of a solvent-detergent-treated fibrin glue. Vox Sang 58:77,
1990.
102.
Banninger H, Hardegger T, Tobler A, et al: Fibrin
glue in surgery: Frequent development of inhibitors of bovine thrombin and human
factor V. Br J Haematol 85:528, 1993.
103.
Hedner U, Erhardtsen E: Potential role for rFVIIa
in transfusion medicine. Transfusion 42:114, 2002.
104.
Kristensen J, Killander A, Hippe E, et al: Clinical
experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis
26(Suppl 1):159, 1996.
105.
Poon MC, Demers C, Jobin F, Wu JW: Recombinant
factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia.
Blood 94:3591, 1999.
106.
White B, McHale J, Ravi N, et al: Successful
use of recombinant FVIIa (NovoSeven) in the management of intractable post-surgical
intra-abdominal haemorrhage. Br J Haematol 107:677, 1999.
107.
Goodnough LT: Treatment of bleeding in the intensive
care unit. In recombinant factor VIIa: potential treatment of critical bleeding
in the future ICU [Goodnough LT, guest editor]. Int Care Med 28:A5, 2002.
108.
Martinowitz U, Kenet G, Segale N, et al: Recombinant
activated factor VII in adjunctive hemorrhage control in trauma. J Trauma 51:431,
2001.
109.
Weiskopf RB: Intraoperative use of recombinant
activated coagulation factor VII. Anesthesiol 96:1287, 2002.
110.
Chuansumrit A, Treepongkaruna S, Phuapradit P:
Successful invasive procedures in children with liver failure using recombinant
factor VIIa. Hemophilia 6:348, 2000.
111.
Papatheodoridis GV, Chung S, Keshav S, et al:
Recombinant factor VIIa is used in a Jehovah's witness with liver cirrhosis to correct
prothrombin time, bleeding time, and thromboelastographic parameters, enabling safe
percutaneous injection of hepatocellular carcinoma [abstract]. Thromb Haemost (Suppl):620,
1999.
112.
O'Connell NM, Perry DJ, Hodgson AJ, et al: Recombinant
FVIIa in the management of uncontrolled hemorrhage. Transfusion 43:1711, 2003.
113.
Key NS: Recombinant FVIIa for intractable hemorrhage:
More questions than answers. Transfusion 43:1649, 2003.
114.
O'Connell NM: Factor XI deficiency—from
molecular genetics to clinical management. Blood Coag Fibrinolysis 14(suppl 1):S59,
2003.
115.
Pickard JD, Kirkpatrick PJ, Melsen T, et al:
Potential role of Novoseven in the prevention of rebleeding following aneurismal
subarachnoid haemorrhage. Blood Coag Fibrinolysis 11(Suppl):S117, 2000.
116.
Laffan M, O'Connell NM, Perry DJ, et al: Analysis
and results of the recombinant factor VIIa extended use registry. Blood Coag Fibrinolysis
14(Suppl):S35, 2003.
117.
Bui JD, Despotis GD, Trulock EP, et al: Fatal
thrombosis after administration of activated prothrombin complex concentrates in
a patient supported by extracorporeal membrane oxygenation who had received activated
recombinant factor VII. J Thoracic Cardiovasc Surg 124:852, 2002.
118.
Goodnough LT, Lubcin DM, Zhang L, Despotis G:
EBYC. Transfusion medicine service policies for recombinant factor VIIa administration.
Transfusion (in press).
119.
Goodnough LT: Recombinant factor VIIa. Washington
University Laboratory Medicine Newsletter 9:1, 2003.
120.
Rosencrantz D, Shander A, Ozawa S, Spence RK:
Establishing a bloodless medicine and surgery center. In
Transfusion Medicine and Alternatives to Blood Transfusion. R J Editions Medicales,
2000.
121.
Goodnough LT, Shander A, Spence RK: Bloodless
medicine: Clinical care without allogenic blood transfusion. Transfusion 43:668–676,
2003.
122.
Kickler TS: Why "bloodless medicine" and how
should we do it? Transfusion 43:550, 2003.
